Peter Kovar

6.4k citations

39 papers · 993 indexed · h-index 19

Impact in

Organic Chemistry top 5%
- Synthesis and biological activity
- Click Chemistry and Applications
Oncology top 10%
- Cancer-related Molecular Pathways

Papers in ⓘ

Oncology 20
- Cancer-related Molecular Pathways 14
- HER2/EGFR in Cancer Research 3
Molecular Biology 27
- DNA Repair Mechanisms 11
- Cancer therapeutics and mechanisms 9
- PI3K/AKT/mTOR signaling in cancer 4

Co-authors: Saul H. Rosenberg (18 shared papers)Zehan Chen (14 shared papers)Hing L. Sham (13 shared papers)Nan‐Horng Lin (12 shared papers)Thomas J. Sowin (11 shared papers)Haiying Zhang (12 shared papers)Zhi‐Fu Tao (9 shared papers)Stephen K. Tahir (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (18 papers)Journal of Medicinal Chemistry (3 papers)SLAS DISCOVERY (2 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Cardiovascular Pharmacology (2 papers)
Partner nations: United States United Kingdom Norway

In The Last Decade

Peter Kovar

39 papers receiving 956 citations

Peers

Countries citing papers authored by Peter Kovar

Since Specialization

Citations

This map shows the geographic impact of Peter Kovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kovar more than expected).

Fields of papers citing papers by Peter Kovar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kovar. The network helps show where Peter Kovar may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Kovar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Kovar Line = papers co-authored together Peter Kovar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics International Journal of Cancer ·Zehan Chen, Zhan Xiao, Wen‐Zhen Gu, John Xue, Mai H. Bui, Peter Kovar, Gaoquan Li, Gary Wang, Zhi‐Fu Tao, Yunsong Tong, Nan‐Horng Lin, Hing L. Sham, Jean Y. J. Wang, Thomas J. Sowin, Saul H. Rosenberg, Haiying Zhang	2006	103
2	Discovery of a Peptide-Based Renin Inhibitor with Oral Bioavailability and Efficacy Science ·Hollis D. Kleinert, Saul H. Rosenberg, William R. Baker, Herman H. Stein, Vered Klinghofer, Jennifer L. Barlow, Kenneth P. Spina, James S. Polakowski, Peter Kovar, Jerome Cohen, Jon F. Denissen	1992	86
3	Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors Journal of Medicinal Chemistry ·Zhi‐Fu Tao, Le Wang, Kent D. Stewart, Zehan Chen, Wendy Gu, Mai-Ha Bui, Philip J. Merta, Haiying Zhang, Peter Kovar, Eric F. Johnson, Chang Park, Russell A. Judge, Saul H. Rosenberg, Thomas J. Sowin, Nan‐Horng Lin	2007	69
4	Rapid Colchicine Competition-Binding Scintillation Proximity Assay Using Biotin-Labeled Tubulin BioTechniques ·Stephen K. Tahir, Peter Kovar, Saul H. Rosenberg, Shi‐Chung Ng	2000	59
5	Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases Bioorganic & Medicinal Chemistry Letters ·Steve Fidanze, Scott Erickson, Gary T. Wang, Robert A. Mantei, Richard F. Clark, Bryan K. Sorensen, Nwe Y. BaMaung, Peter Kovar, Eric F. Johnson, Kerren K. Swinger, Kent D. Stewart, Qian Zhang, Lora A. Tucker, William N. Pappano, Julie L. Wilsbacher, Jieyi Wang, George S. Sheppard, Randy L. Bell, Steven K. Davidsen, Robert D. Hubbard	2010	50
6	Novel sulfonate analogues of combretastatin A-4 Bioorganic & Medicinal Chemistry Letters ·Stephen L. Gwaltney, Hovis Imade, Kenneth J. Barr, Qun Li, Laura Gehrke, R.B. Credo, Robert B. Warner, Jang Yun Lee, Peter Kovar, Jieyi Wang, Michael A. Nukkala, N A Zielinski, David J. Frost, Shi-Chung Ng, Hing L. Sham	2001	49
7	Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3-[[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517) Journal of Medicinal Chemistry ·Saul H. Rosenberg, Kenneth P. Spina, Stephen L. Condon, Jim Polakowski, Zhu Yao, Peter Kovar, Herman H. Stein, Jerome D. Cohen, Jennifer L. Barlow	1993	36
8	Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin, Ping Xia, Peter Kovar, Chang Park, Zehan Chen, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham	2005	35
9	1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase: Synthesis, Preliminary SAR, and Biological Activities Journal of Medicinal Chemistry ·Gary T. Wang, Gaoquan Li, Robert A. Mantei, Zehan Chen, Peter Kovar, Wendy Gu, Zhan Xiao, Haiying Zhang, Hing L. Sham, Thomas J. Sowin, Saul H. Rosenberg, Nan‐Horng Lin	2005	35
10	Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions Bioorganic & Medicinal Chemistry Letters ·Irini Akritopoulou‐Zanze, Brian D. Wakefield, Alan F. Gasiecki, Douglas Kalvin, Eric F. Johnson, Peter Kovar, Stevan W. Djurić	2011	34
11	Sport activities differentiating match-play improvement in elite youth footballers – a 2-year longitudinal study Journal of Sports Sciences ·Arne Güllich, Peter Kovar, Sebastian Zart, Ansgar Reimann	2016	34
12	A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growth Molecular Cancer Therapeutics ·Zehan Chen, Philip J. Merta, Nan-Hong Lin, Stephen K. Tahir, Peter Kovar, Hing L. Sham, Haiying Zhang	2005	34
13	Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors Bioorganic & Medicinal Chemistry ·Yunsong Tong, Akiyo Claiborne, Kent D. Stewart, Chang Park, Peter Kovar, Zehan Chen, R.B. Credo, Wen‐Zhen Gu, Stephen L. Gwaltney, Russell A. Judge, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham, Thomas J. Sowin, Nan‐Horng Lin	2007	33
14	Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Gaoquan Li, Lisa Hasvold, Zhi‐Fu Tao, Gary T. Wang, Stephen L. Gwaltney, Jyoti Patel, Peter Kovar, R.B. Credo, Zehan Chen, Haiying Zhang, Chang Park, Hing L. Sham, Thomas J. Sowin, Saul H. Rosenberg, Nan‐Horng Lin	2006	29
15	Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase Bioorganic & Medicinal Chemistry Letters ·David J. Augeri, Dave Janowick, Douglas Kalvin, Gerry Sullivan, John J. Larsen, Daniel A. Dickman, Hong Ding, Jerry D. Cohen, Jang Lee, Robert B. Warner, Peter Kovar, Sajeev Cherian, Badr Saeed, Haichao Zhang, Steve Tahir, Shi-Chung Ng, Hing L. Sham, Saul H. Rosenberg	1999	28
16	Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao, Gaoquan Li, Yunsong Tong, Kent D. Stewart, Zehan Chen, Mai-Ha Bui, Philip J. Merta, Chang Park, Peter Kovar, Haiying Zhang, Hing L. Sham, Saul H. Rosenberg, Thomas J. Sowin, Nan‐Horng Lin	2007	25
17	Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1 SLAS DISCOVERY ·Kenneth M. Comess, Jonathan D. Trumbull, Chang Park, Zehan Chen, Russell A. Judge, Martin J. Voorbach, Michael Coen, Lan Gao, Hua Tang, Peter Kovar, Xueheng Cheng, Mark E. Schurdak, Haiying Zhang, Tom Sowin, David J. Burns	2006	24
18	Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases Bioorganic & Medicinal Chemistry Letters ·Gary T. Wang, Robert A. Mantei, Robert D. Hubbard, Julie L. Wilsbacher, Qian Zhang, Lora A. Tucker, Xiaoming Hu, Peter Kovar, Eric F. Johnson, Donald J. Osterling, Jennifer J. Bouska, Jieyi Wang, Steven K. Davidsen, Randy L. Bell, George S. Sheppard	2010	22
19	Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao, Gaoquan Li, Yunsong Tong, Zehan Chen, Philip J. Merta, Peter Kovar, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham, Thomas J. Sowin, Nan‐Horng Lin	2007	22
20	Novel sulfonate Derivatives: potent antimitotic agents Bioorganic & Medicinal Chemistry Letters ·Stephen L. Gwaltney, Hovis Imade, Qun Li, Laura Gehrke, R.B. Credo, Robert B. Warner, Jang Yun Lee, Peter Kovar, David J. Frost, Shi-Chung Ng, Hing L. Sham	2001	18

About Peter Kovar

Peter Kovar is a scholar working on Oncology, Molecular Biology, Genetics, Cardiology and Cardiovascular Medicine and Cell Biology, having authored 39 papers that have together received 993 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), DNA Repair Mechanisms (11 papers), Cancer therapeutics and mechanisms (9 papers), Renin-Angiotensin System Studies (6 papers), Click Chemistry and Applications (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Organic Chemistry (379 citations), Oncology (261 citations), Computational Theory and Mathematics (142 citations), Molecular Biology (612 citations) and Toxicology (21 citations). Peter Kovar has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Saul H. Rosenberg, Zehan Chen, Hing L. Sham, Nan‐Horng Lin, Thomas J. Sowin, Haiying Zhang, Zhi‐Fu Tao, Stephen K. Tahir, Eric F. Johnson and Gaoquan Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, SLAS DISCOVERY, ACS Medicinal Chemistry Letters and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact